DEFEROXAMINE-INDUCED RESTORATION OF HEMATOPOIESIS IN MYELOFIBROSIS SECONDARY TO MYELODYSPLASIA

被引：21

作者：

MARSH, JH

HUNDERT, M

SCHULMAN, P

机构：

[1] Don Monti Division of Oncology, Department of Medicine, North Shore University Hospital, Cornell University Medical Center, Manhasset, New York, 11030

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1990年 / 76卷 / 01期

关键词：

D O I：

10.1111/j.1365-2141.1990.tb07851.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：148 / 149

页数：2

共 6 条

[1]

KELSEY PR, 1987, CLIN LAB HAEMATOL, V9, P1

[2]

LAWLER SD, 1985, MYELOFIBROSIS PATHOP, P167

[3] MYELOFIBROSIS - PROGNOSTIC FACTORS AND TREATMENT [J].

MANOHARAN, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (03) :295-298

[4]

PAMPHILON DH, 1987, EUR J HAEMATOL, V38, P279

[5] DEFEROXAMINE TREATMENT AS A RISK FACTOR FOR ZYGOMYCETE INFECTION [J].

SANE, A ;

MANZI, S ;

PERFECT, J ;

HERZBERG, AJ ;

MOORE, JO .

JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :151-152

[6] MYELOFIBROSIS - A CONCISE REVIEW OF CLINICAL AND PATHOLOGIC FEATURES AND TREATMENT [J].

SMITH, RE ;

CHELMOWSKI, MK ;

SZABO, EJ .

AMERICAN JOURNAL OF HEMATOLOGY, 1988, 29 (03) :174-180

← 1 →